| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.3M | -6.4% |
| Cost of Revenue | $5.1M | +7.1% |
| R&D Expense | $1.5M | -7.8% |
| SG&A Expense | $6.1M | +2.2% |
| Operating Income | -$12.7M | -14.0% |
| Interest Expense | $18K | +12.5% |
| Net Income | -$12.5M | -12.6% |
| EPS (Basic) | -$17.58 | -1329.3% |
| EPS (Diluted) | -$17.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -19.9% |
| Accounts Receivable | $1.4M | +98.3% |
| Current Assets | $3.6M | -56.4% |
| Total Assets | $9.4M | -40.9% |
| Current Liabilities | $5.8M | -4.6% |
| Total Liabilities | $6.0M | -0.6% |
| Stockholders' Equity | $3.3M | -66.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | -42.3% |
| Capital Expenditures | $32K | +62.0% |
| Investing Cash Flow | $2.0M | +127.4% |
| Financing Cash Flow | $5.8M | +8108.5% |
| Free Cash Flow | -$8.3M | -42.4% |
| -1329.3% |